Mark Westcott, MD, FSIR

Medical Director
ABK Biomedical Inc., France

Disclosure information not submitted.

Presentation(s):

• 75 - A Clinical Comparison Between Nuclear Medicine and CT-based Post-treatment Dosimetry Following 90Y-radioembolization with Multi-modality Imageable Eye90 Microspheres

  Sunday, April 12, 2026
  3:36 PM - 3:45 PM ET